Mario P. Colombo

Fondazione IRCCS Istituto Nazionale dei Tumori — Italy

Immunology and Microbiology · Life Sciences

90h-index32.6kcitations926works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(184), Immune cells in cancer(153), Cancer Immunotherapy and Biomarkers(137), Cancer Research and Treatments(121), CAR-T cell therapy research(110)

Publications926 total

Supplementary Methods from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
2025Open Access
Supplementary Figures from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
2025Open Access
SupplementaryTables S7-S16 from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
2025Open Access
Supplementary Tables S1-S6, S17-S18 from Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
2025Open Access
Neutrophil extracellular traps in cancer: immune modulation, therapy resistance, and the dilemma of targeting
Cell Death and Disease·2025Open Access
Figure S3 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
Figure S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
Figure S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
Supplementary Data Table S2 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
Figure S4 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
Supplementary Data Table S1 from JMJD6 Shapes a Pro-tumor Microenvironment via ANXA1-Dependent Macrophage Polarization in Breast Cancer
2025Open Access
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on Tregs
Journal of Experimental & Clinical Cancer Research·2025Open Access
Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone
Journal of Clinical Investigation·2025Open Access
172 | AGGRESSIVE B‐CELL LYMPHOMAS RETAIN ATR‐DEPENDENT DETERMINANTS OF T‐CELL EXCLUSION FROM THE GERMINAL CENTER DARK ZONE
Hematological Oncology·2025Open Access
Correction: CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
Journal of Experimental & Clinical Cancer Research·2025· 1 citedOpen Access
Extraction of a stromal metastatic gene signature in breast cancer via spatial profiling
Journal of Experimental & Clinical Cancer Research·2025Open Access
A0496 – Use of multiparametric magnetic resonance imaging in bladder cancer staging: prospective observational study and analysis of radiologist learning curve
European Urology·2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell lines
Epigenomics·2025· 3 citedOpen Access
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
Journal of Experimental & Clinical Cancer Research·2025· 11 citedOpen Access
Abstract B017: The double-edged sword of cystatin B in luminal-like and triple-negative breast cancers
Cancer Research·2024
page 1 of 47Next →

Frequent Co-authors

Claudia Chiodoni(10), Sabina Sangaletti(9), Vincenzo Bronte(6), Cristiana Guiducci(6), Silvia Piconese(6), Claudio Tripodo(6), Antonella Stoppacciaro(6), Cecilia Melani(6), Emma Di Carlo(5), Guido Forni(5), Piero Musiani(5), Mariella Parenza(5), Giorgio Parmiani(5), Antonio Sica(4), Barbara Valzasina(4), Pier‐Luigi Lollini(4), Dmitry I. Gabrilovich(3), Paolo Serafini(3), Carmela De Santo(3), Ilaria Marigo(3)